Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20172
20182
20212
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Betta Pharmaceuticals Co., Ltd.1
China International Medical Foundation1
Ensem Therapeutics1
Fudan University1
Hoffmann-La Roche1
Innolake Biopharm1
Jacobio Pharmaceuticals Co., Ltd.1
Second Affiliated Hospital of Guangzhou Medical University1
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms13
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Lung Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Neoplasms3
Neoplasms by Site3
Ovarian Neoplasms3
Sarcoma3
Uterine Cervical Neoplasms3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.